Radiation Oncology
Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.
Recent Discussions
How would you treat an immunosuppressed patient with high risk cutaneous SCC of the axilla with node positivity on axillary node dissection?
I would probably recommend adjuvant radiotherapy to a dose of 56.1-60 Gy in 30 fractions, using integrated boost to regions where the gross nodal disease was prior to surgery. Scar should receive 60 Gy if there was extranodal extension. Elective nodal irradiation of the supraclavicular and internal ...
What early stage breast cancer patients would you give IOeRT?
I think given data from ELIOT update (11% LR with electron IORT vs. 2% WBI) and the TARGIT-A update, there is a limited role for IORT as monotherapy at this time, particularly when options like 5 fx PBI and 5 fx WBI are now possible. The ABS guidelines do not recommend either IORT technique which is...
Under what circumstances would you consider reirradiation for a patient with recurrent previously irradiated early stage laryngeal cancer now s/p salvage laryngectomy?
This type of patient would have been allowable on the GETUG trial which randomized patients after surgical salvage to no further treatment or re-irradiation with chemotherapy. The study showed a DFS advantage, but no OS advantage. There were more deaths due to treatment in the treatment arm (5 vs 0)...
Does the extent of ENE affect your recommendation for concurrent chemotherapy in HPV+ OPSCC patients planned for adjuvant RT?
I'm wary of de-escalating treatment without phase 3 data supporting that decision. So any ECE, I treat with 66 Gy and concurrent chemo.
What is your treatment approach for p16+ oropharyngeal carcinoma with one positive node on neck dissection?
The question is quite broad and covers varying scenarios. My sense though is the question is asking about if/when would I recommend adjuvant radiation if an unirradiated patient has a neck dissection and 1 node is found. I will address the scenarios where the primary is either absent (ie unknown or ...
In clinically node positive vulvar cancer, are you recommending bilateral inguinal LND or nodal debulking followed by adjuvant radiotherapy?
I am sure there is wide variation in practice as there is no prospective study to guide care. Our approach is definitive chemo RT with the removal of only residual persistent node. Richman et al., PMID 32981696
When contouring locally advanced NSCLC, how do you define your ITV if your iGTV overlaps with an OAR?
For locally advanced lung, I have 2 slightly different approaches for primary vs nodes. For primary, GTV to iGTV (with 4DCT or DIBH scans x 3 at sim in certain cases) to CTV (5 mm expansion cropped to anatomical barriers to spread) to PTV (5 mm uniform expansion). I let the iGTV overlap the esophagu...
What is the appropriate treatment for marginal zone lymphoma of the parotid following surgery?
Definitive radiation therapy is the standard treatment for a patient with an uncomplicated case of localized marginal zone lymphoma of the parotid gland. The CTV would encompass the entire gland and the total dose would be 24 Gy. Occasionally patients will be diagnosed with MZL after parotidectomy, ...
What data is there for using SRS to treat more than 3 lesions?
The short answer to this is that there are no randomized trials supporting SRS alone for more than 4 lesions, in comparison to SRS and whole brain radiotherapy, or whole brain radiotherapy alone. This does not mean that SRS alone is contraindicated, and I believe that SRS alone can be used as up fro...
When is it appropriate to use adjuvant whole pelvis radiotherapy for Stage I endometrial adenocarcinoma?
The indications have been changing with the publications of GOG 99, PORTEC 1 and 2 , the Swedish and ASTEC studies, and the interpretation of data with the confounding factor of nodal dissection.At present, I would/do consider pelvic RT for Stage IB with grade 3 disease and Stage Ia with grade 3 and...